American Express raises 2026 earnings guidance after record third-quarter revenue

Impact · against what's priced in

American Express's guidance raise and record revenue provide concrete evidence against the market's assumption of a sharp growth deceleration, though short-term EPS gains were padded by temporary tax and provision benefits. Ondine Biomedical reports significant real-world efficacy for its Steriwave technology.

AXP+0.40

Challenges what's priced in

The price assumes

Sustaining recent 10-11% billed business and revenue growth instead of decelerating to the 1.6% the price requires